此外,为了进一步提高疗效,未来的研究可以探索将131I-apamistamab与其他减低强度的预处理方案或新型药物相结合,例如联合使用靶向药物、免疫检查点抑制剂或表观遗传调节剂。这种综合治疗策略有望增强抗白血病效应。 尽管131I-apamistamab预处理...
中文名称:碘(I131)艾妥单抗 英文名称:Iodine (131I) Apamistamab CAS:2097132-02-8 纯度:95% 包装信息:100ug;500ug;1mg 备注:现货,仅供科研用途 武汉科斯坦生物科技有限公司 联系电话: 027-65317797 15926423062 产品介绍: 中文名称:碘(I131)艾妥单抗 ...
抗体名:Iodine (131I) Apamistamab ( 碘(I131)艾妥单抗 ) 浓度:1mg/ml % 靶点:PTPRC/CD45[Homo sapiens] 用途:科研实验 纯度:95% 产地:中国 品牌:chemstan 货号:CSD00444 用途:科研实验 保质期:-20℃/1 year 包装规格:100μg 保存条件:store at -80℃ ...
英文别名: Apamistamab;Apamistamab (anti-PTPRC);Iodine (131I) Apamistamab;Research Grade Apamistamab;Research Grade Apamistamab (DHC34001) 中文名: Iodine (131I) Apamistamab 中文别名: 艾妥单抗;碘(I131)艾妥单抗 CBNumber: CB68080990 分子式: 分子量: 0 MOL File: Mol file 化学...
P730 Introduction: The SIERRA trial investigated targeted bone marrow conditioning prior to hematopoietic cell transplant using Iomab-B (I131-apamistamab) delivered as a personalized dose ranging from 300 to 1030 mCi (median 660 mCi), requiring administration in an in-patient setting with radiation...
UNII号 71RR81V666 化学名 IODINE I-131 APAMISTAMAB CAS号 2097132-02-8 结构式图片 NCIT码 C2527 INN_ID 10856 扩展信息 VIP试用医疗器械查询APP下载客服中心常见问题数据可视化数据分析挖掘系统网站地图业务介绍友情链接 400-678-0778 投诉热线: (023) 6262 8397 邮箱: tousu@yaozh...
241491 Introduction: Iomab-B (131I-apamistamab), a radioimmunoconjugate to anti-CD45, delivers high-dose targeted radiation to hematopoietic cells allowing for myeloablation and eradication of leukemic cells prior to allogeneic hematopoietic cell transplant (HCT). Very few patients with TP53 ...
Introduction Iomab-B (131I-apamistamab), a radioimmunoconjugate to CD45, delivers high-dose targeted radiation to hematopoietic cells for myeloablation and eradication of leukemic cells, enabling patients with active relapsed/refractory acute myeloid leukemia (R/R AML) to proceed to allogeneic ...
Iomab-B (131I-apamistamab) delivers high-dose targeted radiation to CD45-expressing cells, producing antileukemic effect and myeloablation while limiting off-target toxicity. In SIERRA, Iomab-B-led alloHCT improved outcomes in active R/R AML patients (shown at June 2022 data cutoff). We ...
Because of the administered activity of 131I (300-1030 mCi, mean ~600 mCi), patients are isolated for several days after the drug administration before being discharged. Radiation safety procedures with rolling lead shields and blankets were implemented to ensure compliance with local regulations ...